NCT06191042 - A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

June 23, 2025

Study Completion Date

June 23, 2025

Conditions

Psoriasis VulgarisPsoriatic Arthritis

Interventions

DRUG

si-544

Subcutaneous injection in the abdomen

DRUG

Placebo

Subcutaneous injection in the abdomen

Trial Locations (4)

selectION Clinical Trial Site, Bad Bentheim

selectION Clinical Trial Site, Berlin

selectION Clinical Trial Site, Blankenfelde-Mahlow

selectION Clinical Trial Site, Hamburg